Cover Image
市場調查報告書

PTCA冠狀動脈塗藥氣球 (DEB):開發平台分析

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015

出版商 GlobalData 商品編碼 336864
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
PTCA冠狀動脈塗藥氣球 (DEB):開發平台分析 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015
出版日期: 2015年07月07日 內容資訊: 英文 48 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的PTCA (經皮冠狀動脈形成術) 冠狀動脈用藥物釋放型球囊 (DEB) 之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各地區·各領域詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),彙整近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • PTCA冠狀動脈塗藥氣球 (DEB) 概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:法規各途徑
  • 開發中產品:各認証時期 (估計)
  • 現在進行中的臨床實驗

第4章 PTCA冠狀動脈塗藥氣球 (DEB):正在開發的開發中產品 (各企業)

  • PTCA冠狀動脈塗藥氣球的開發企業:開發中產品 (各開發階段)
  • PTCA冠狀動脈塗藥氣球:各開發階段的開發中產品一覽

第5章 PTCA冠狀動脈塗藥氣球 (DEB) 的開發企業·產品概要

  • Acrostak (Schweiz) AG
    • 開發中產品及進行中的臨床實驗概要
  • B. Braun Melsungen AG
  • Concept Medical Inc
  • Eurocor GmbH
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • Maxcor Inc.
  • Micell Technologies, Inc.
  • QualiMed Innovative Medizinprodukte GmbH
  • The Spectranetics Corporation
  • Vascular Nanotransfer Technologies

第6章 PTCA冠狀動脈塗藥氣球 (DEB):近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0050EPD

GlobalData's Medical Devices sector report, "Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloons (DEB) - Pipeline Review, 2015" provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Drug Eluting Balloon (DEB) products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) products and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) products under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloons (DEB) Overview

3. Products under Development

  • 3.1. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • 3.2. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Territory
  • 3.3. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path
  • 3.4. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date
  • 3.5. PTCA Coronary Drug Eluting Balloons (DEB) - Ongoing Clinical Trials

4. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products under Development by Companies

  • 4.1. PTCA Coronary Drug Eluting Balloons (DEB) Companies - Pipeline Products by Stage of Development
  • 4.2. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development

5. PTCA Coronary Drug Eluting Balloons (DEB) Companies and Product Overview

  • 5.1. Acrostak (Schweiz) AG Company Overview
    • 5.1.1. Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. B. Braun Melsungen AG Company Overview
    • 5.2.1. B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Concept Medical Inc Company Overview
    • 5.3.1. Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Eurocor GmbH Company Overview
    • 5.4.1. Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview
    • 5.5.1. Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Maxcor Inc. Company Overview
    • 5.6.1. Maxcor Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Micell Technologies, Inc. Company Overview
    • 5.7.1. Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. QualiMed Innovative Medizinprodukte GmbH Company Overview
    • 5.8.1. QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. The Spectranetics Corporation Company Overview
    • 5.9.1. The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Vascular Nanotransfer Technologies Company Overview
    • 5.10.1. Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6. PTCA Coronary Drug Eluting Balloons (DEB)- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • Table 2: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Territory
  • Table 3: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path
  • Table 4: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date
  • Table 5: PTCA Coronary Drug Eluting Balloons (DEB) - Ongoing Clinical Trials
  • Table 6: PTCA Coronary Drug Eluting Balloons (DEB) Companies - Pipeline Products by Stage of Development
  • Table 7: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • Table 8: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Genie Catheter - Product Status
  • Table 10: Genie Catheter - Product Description
  • Table 11: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: SeQuent Please - Product Status
  • Table 13: SeQuent Please - Product Description
  • Table 14: B. Braun Melsungen AG - Ongoing Clinical Trials Overview
  • Table 15: SeQuent Please - A Prospective Randomized Multicenter Non-inferiority Clinical Study to Determine the Safety and Performance of the Agent Paclitaxel-coated PTCA Balloon Catheter (Hemoteq) Compared to the SeQuent Please Paclitaxel-releasing Coronary Balloon Catheter (B.Braun) for the Treatment of Coronary In-stent Restenosis (AGENT-ISR)
  • Table 16: SeQuent Please - A Prospective, Randomized, Controlled, Open Label, Multicenter Trial to Test the Non-inferiority of Drug Eluting Balloon Versus Drug Eluting Stent Treatment in de Novo Stenoses of Small Native Vessels Regarding Efficacy and Safety
  • Table 17: SeQuent Please - Absorb Bioresorbable Scaffold Vs. Drug Coated Balloon for Treatment of In-stent-restenosis
  • Table 18: SeQuent Please - Bare Metal Stent Versus Drug Coated Balloon with Provisional Stenting in Non-ST-Elevation Myocardial Infarction
  • Table 19: SeQuent Please - Comprehensive Imaging and Interventional Therapy Studies for Arteriogenic Erectile Dysfunction and Lower Urinary Tract Symptoms: a Multi-modality, Multi-specialty Collaborative Study (PERFECT Program)
  • Table 20: SeQuent Please - DARE-Trial: Drug Eluting bAlloon for In-stent REstenosis. Multi-center, Randomized Trial to Study the Effect of the SeQuent Please Drug-eluting Balloon Versus the Xience Prime Drug-eluting Stent for the Treatment of In-stent Restenosis
  • Table 21: SeQuent Please - Drug-Eluting Balloon in Stable and Unstable Angina: A Randomized Controlled Non-inferiority Trial
  • Table 22: SeQuent Please - Effect of Combination of Non-slip Element Balloon (NSE) and Drug-coated Balloon (DCB) for In-stent Restenosis Lesions (ELEGANT)
  • Table 23: SeQuent Please - Randomized Controlled Trial of Drug Coated Balloon Compared to Bare Metal Stent Using FFR-guidance for the Treatment of de Novo Coronary Artery Lesions
  • Table 24: SeQuent Please - The Efficacy and Safety of Paclitaxel-eluting SeQuent Please Drug-Eluting Balloon for Treatment of lesiOns in Native smalL coronarY Arteries (DEB-ONLY)
  • Table 25: SeQuent Please - Treatment of Drug-Eluting Stent Restenosis Using Drug-Eluting Stents vs. Drug-Coated Balloon for Preventing Recurrent In-Stent Restenosis
  • Table 26: SeQuent Please - Trial of a Novel Paclitaxel-coated Balloon with Citrate Excipient for Restenosis in -Limus Analogue Drug-eluting Coronary Stents
  • Table 27: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Magic Touch - Product Status
  • Table 29: Magic Touch - Product Description
  • Table 30: Concept Medical Inc - Ongoing Clinical Trials Overview
  • Table 31: Magic Touch - Assessment of the Novel MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions
  • Table 32: Magic Touch - First-in-man Assessment of the Novel Magictouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions
  • Table 33: Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: DIOR Paclitaxel-Eluting Coronary Balloon Catheter - Product Status
  • Table 35: DIOR Paclitaxel-Eluting Coronary Balloon Catheter - Product Description
  • Table 36: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: PTCA Drug Eluting Balloon - Product Status
  • Table 38: PTCA Drug Eluting Balloon - Product Description
  • Table 39: Maxcor Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Next Generation Rapamycin (Sirolimus)-Based DEB - Product Status
  • Table 41: Next Generation Rapamycin (Sirolimus)-Based DEB - Product Description
  • Table 42: Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Drug-Coated Balloon - Product Status
  • Table 44: Drug-Coated Balloon - Product Description
  • Table 45: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Kinesyx Next Generation Drug Coated Balloon - Product Status
  • Table 47: Kinesyx Next Generation Drug Coated Balloon - Product Description
  • Table 48: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Drug Coated AngioSculpt Balloon - Product Status
  • Table 50: Drug Coated AngioSculpt Balloon - Product Description
  • Table 51: Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Mitomycin-Based DCB - Coronary - Product Status
  • Table 53: Mitomycin-Based DCB - Coronary - Product Description
  • Table 54: Paclitaxel-Based DCB - Coronary - Product Status
  • Table 55: Paclitaxel-Based DCB - Coronary - Product Description
  • Table 56: Glossary

List of Figures

  • Figure 1: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development
  • Figure 2: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Territory
  • Figure 3: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path
  • Figure 4: PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date
  • Figure 5: PTCA Coronary Drug Eluting Balloons (DEB) - Ongoing Clinical Trials
Back to Top